Finance

Beta
Lists
TG1N:FRA
Armata Pharmaceuticals Inc
€6.45
-3.73%
(-0.25) 1D
Jun 3, 10:00:00 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for TG1N...
Open
€6.75
High
€6.75
Low
€6.45
Mkt. cap
278.63M
Avg. vol.
21.00
Volume
0.00
52-wk high
€12.70
52-wk low
€1.48
No. of employees
61
Open
€6.75
High
€6.75
Low
€6.45
Mkt. cap
278.63M
Avg. vol.
21.00
Volume
0.00
52-wk high
€12.70
52-wk low
€1.48
No. of employees
61
News stories
From sources across the web
About Armata Pharmaceuticals Inc
CEO-
Employees61
Founded1989
HeadquartersLos Angeles, California, United States
SectorBiotechnology
Websitearmatapharma.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
2.17M
1.16M
1.08M
789.00K
Cost of goods sold
167.00K
5.82M
-1.93M
-
Cost of revenue
167.00K
5.82M
-1.93M
-
Research and development expenses
6.23M
-
-
6.11M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.62M
3.11M
11.43M
3.46M
Operating expense
8.85M
3.11M
11.43M
9.57M
Total operating expenses
9.01M
8.94M
9.50M
9.57M
Operating income
-6.84M
-7.78M
-8.41M
-8.78M
Other non operating income
-
-
-
-
EBT including unusual items
-16.30M
-26.68M
-124.30M
-115.35M
EBT excluding unusual items
-10.54M
-12.03M
-13.11M
-14.28M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-16.30M
-26.68M
-124.30M
-115.35M
Net profit margin
-751.27%
-2,301.55%
-11,456.04%
-14,619.26%
Earnings per share
-0.29
-0.33
-0.36
-
Interest and investment income
108.00K
90.00K
131.00K
60.00K
Interest expense
-3.81M
-4.35M
-4.83M
-5.56M
Net interest expenses
-3.70M
-4.26M
-4.70M
-5.50M
Depreciation and amortization charges
-
-
-
-
EBITDA
-6.48M
-7.41M
-7.99M
-8.33M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer